human os cell lines saos2 Search Results


human osteosarcoma cell line saos-2  (Pasteur Institute)
90
Pasteur Institute human osteosarcoma cell line saos-2
Human Osteosarcoma Cell Line Saos 2, supplied by Pasteur Institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human osteosarcoma cell line saos-2/product/Pasteur Institute
Average 90 stars, based on 1 article reviews
human osteosarcoma cell line saos-2 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
human osteosarcoma cell line saos2 htl01001  (Biologica Environmental Services)
90
Biologica Environmental Services human osteosarcoma cell line saos2 htl01001
Human Osteosarcoma Cell Line Saos2 Htl01001, supplied by Biologica Environmental Services, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human osteosarcoma cell line saos2 htl01001/product/Biologica Environmental Services
Average 90 stars, based on 1 article reviews
human osteosarcoma cell line saos2 htl01001 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
human saos-2 cell line  (Marburg GmbH)
90
Marburg GmbH human saos-2 cell line
Human Saos 2 Cell Line, supplied by Marburg GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human saos-2 cell line/product/Marburg GmbH
Average 90 stars, based on 1 article reviews
human saos-2 cell line - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
human os cell lines (u2s2, saos-2, sjsa-1, and hos)  (iCell Gene Therapeutics)
90
iCell Gene Therapeutics human os cell lines (u2s2, saos-2, sjsa-1, and hos)
The qPCR result of seven lncRNAs in five OS highly <t>metastasis</t> and weakly metastasis cell lines. ( A ) AL512422.1. ( B ) AL008718.3. ( C ) AC006033.2. ( D ) AL357507.1. ( E ) AL360182.2. ( F ) C5orf66-AS1. ( G ) CEBPA-DT. *<0.05, **<0.01, ***<0.001, ****<0.0001.
Human Os Cell Lines (U2s2, Saos 2, Sjsa 1, And Hos), supplied by iCell Gene Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human os cell lines (u2s2, saos-2, sjsa-1, and hos)/product/iCell Gene Therapeutics
Average 90 stars, based on 1 article reviews
human os cell lines (u2s2, saos-2, sjsa-1, and hos) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
human osteosarcoma cell lines hos, saos-2 and mg63  (Servicebio Inc)
90
Servicebio Inc human osteosarcoma cell lines hos, saos-2 and mg63
SLC38A5 is up-regulated in osteosarcoma and associated with a poor prognosis. ( A ) The expression patterns of SLC38A5 across various tumors in the TCGA dataset based on the TIMER database. ( B ) The relative mRNA level of SLC38A5 in tumor ( n = 12) and adjacent normal tissues ( n = 12) based on clinical samples. ( C ) The protein level of SLC38A5 was assessed in osteosarcoma tissues and adjacent normal counterparts using western blot. ( D ) The quantitative analysis of the western blot result. ( E-F ) The protein level of SLC38A5 in human osteoblastic cell (hFOB1.19) and osteosarcoma cell lines (HOS, Saos-2, <t>MG63,</t> U2OS, 143B). ( G ) The mRNA level of SLC38A5 in different cell lines. (H-I) Kaplan–Meier survival analysis of SLC38A5 in osteosarcoma based on the TARGET database ( n = 86) and GSE21257 dataset ( n = 53). The median value of SLC38A5 expression is the cut-off for high and low expression. Results from three independent experiments are summarized in a histogram format. * P < 0.05, ** P < 0.01, *** P < 0.001
Human Osteosarcoma Cell Lines Hos, Saos 2 And Mg63, supplied by Servicebio Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human osteosarcoma cell lines hos, saos-2 and mg63/product/Servicebio Inc
Average 90 stars, based on 1 article reviews
human osteosarcoma cell lines hos, saos-2 and mg63 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
human osteosarcoma saos-2 cell line  (Merck KGaA)
90
Merck KGaA human osteosarcoma saos-2 cell line
SLC38A5 is up-regulated in osteosarcoma and associated with a poor prognosis. ( A ) The expression patterns of SLC38A5 across various tumors in the TCGA dataset based on the TIMER database. ( B ) The relative mRNA level of SLC38A5 in tumor ( n = 12) and adjacent normal tissues ( n = 12) based on clinical samples. ( C ) The protein level of SLC38A5 was assessed in osteosarcoma tissues and adjacent normal counterparts using western blot. ( D ) The quantitative analysis of the western blot result. ( E-F ) The protein level of SLC38A5 in human osteoblastic cell (hFOB1.19) and osteosarcoma cell lines (HOS, Saos-2, <t>MG63,</t> U2OS, 143B). ( G ) The mRNA level of SLC38A5 in different cell lines. (H-I) Kaplan–Meier survival analysis of SLC38A5 in osteosarcoma based on the TARGET database ( n = 86) and GSE21257 dataset ( n = 53). The median value of SLC38A5 expression is the cut-off for high and low expression. Results from three independent experiments are summarized in a histogram format. * P < 0.05, ** P < 0.01, *** P < 0.001
Human Osteosarcoma Saos 2 Cell Line, supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human osteosarcoma saos-2 cell line/product/Merck KGaA
Average 90 stars, based on 1 article reviews
human osteosarcoma saos-2 cell line - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
human osteoblastic saos-2 cells  (Tanabe)
90
Tanabe human osteoblastic saos-2 cells
SLC38A5 is up-regulated in osteosarcoma and associated with a poor prognosis. ( A ) The expression patterns of SLC38A5 across various tumors in the TCGA dataset based on the TIMER database. ( B ) The relative mRNA level of SLC38A5 in tumor ( n = 12) and adjacent normal tissues ( n = 12) based on clinical samples. ( C ) The protein level of SLC38A5 was assessed in osteosarcoma tissues and adjacent normal counterparts using western blot. ( D ) The quantitative analysis of the western blot result. ( E-F ) The protein level of SLC38A5 in human osteoblastic cell (hFOB1.19) and osteosarcoma cell lines (HOS, Saos-2, <t>MG63,</t> U2OS, 143B). ( G ) The mRNA level of SLC38A5 in different cell lines. (H-I) Kaplan–Meier survival analysis of SLC38A5 in osteosarcoma based on the TARGET database ( n = 86) and GSE21257 dataset ( n = 53). The median value of SLC38A5 expression is the cut-off for high and low expression. Results from three independent experiments are summarized in a histogram format. * P < 0.05, ** P < 0.01, *** P < 0.001
Human Osteoblastic Saos 2 Cells, supplied by Tanabe, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human osteoblastic saos-2 cells/product/Tanabe
Average 90 stars, based on 1 article reviews
human osteoblastic saos-2 cells - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
human osteosarcoma saos-2 cell line  (Verlag GmbH)
90
Verlag GmbH human osteosarcoma saos-2 cell line
SLC38A5 is up-regulated in osteosarcoma and associated with a poor prognosis. ( A ) The expression patterns of SLC38A5 across various tumors in the TCGA dataset based on the TIMER database. ( B ) The relative mRNA level of SLC38A5 in tumor ( n = 12) and adjacent normal tissues ( n = 12) based on clinical samples. ( C ) The protein level of SLC38A5 was assessed in osteosarcoma tissues and adjacent normal counterparts using western blot. ( D ) The quantitative analysis of the western blot result. ( E-F ) The protein level of SLC38A5 in human osteoblastic cell (hFOB1.19) and osteosarcoma cell lines (HOS, Saos-2, <t>MG63,</t> U2OS, 143B). ( G ) The mRNA level of SLC38A5 in different cell lines. (H-I) Kaplan–Meier survival analysis of SLC38A5 in osteosarcoma based on the TARGET database ( n = 86) and GSE21257 dataset ( n = 53). The median value of SLC38A5 expression is the cut-off for high and low expression. Results from three independent experiments are summarized in a histogram format. * P < 0.05, ** P < 0.01, *** P < 0.001
Human Osteosarcoma Saos 2 Cell Line, supplied by Verlag GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human osteosarcoma saos-2 cell line/product/Verlag GmbH
Average 90 stars, based on 1 article reviews
human osteosarcoma saos-2 cell line - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


The qPCR result of seven lncRNAs in five OS highly metastasis and weakly metastasis cell lines. ( A ) AL512422.1. ( B ) AL008718.3. ( C ) AC006033.2. ( D ) AL357507.1. ( E ) AL360182.2. ( F ) C5orf66-AS1. ( G ) CEBPA-DT. *<0.05, **<0.01, ***<0.001, ****<0.0001.

Journal: Cancer Management and Research

Article Title: A Novel Predictive Model Associated with Osteosarcoma Metastasis

doi: 10.2147/CMAR.S332387

Figure Lengend Snippet: The qPCR result of seven lncRNAs in five OS highly metastasis and weakly metastasis cell lines. ( A ) AL512422.1. ( B ) AL008718.3. ( C ) AC006033.2. ( D ) AL357507.1. ( E ) AL360182.2. ( F ) C5orf66-AS1. ( G ) CEBPA-DT. *<0.05, **<0.01, ***<0.001, ****<0.0001.

Article Snippet: Highly metastasis human OS cell lines (MNNG) and weakly metastasis human OS cell lines (U2S2, SAOS-2, SJSA-1, and HOS) were purchased from iCell (Shanghai, China).

Techniques:

SLC38A5 is up-regulated in osteosarcoma and associated with a poor prognosis. ( A ) The expression patterns of SLC38A5 across various tumors in the TCGA dataset based on the TIMER database. ( B ) The relative mRNA level of SLC38A5 in tumor ( n = 12) and adjacent normal tissues ( n = 12) based on clinical samples. ( C ) The protein level of SLC38A5 was assessed in osteosarcoma tissues and adjacent normal counterparts using western blot. ( D ) The quantitative analysis of the western blot result. ( E-F ) The protein level of SLC38A5 in human osteoblastic cell (hFOB1.19) and osteosarcoma cell lines (HOS, Saos-2, MG63, U2OS, 143B). ( G ) The mRNA level of SLC38A5 in different cell lines. (H-I) Kaplan–Meier survival analysis of SLC38A5 in osteosarcoma based on the TARGET database ( n = 86) and GSE21257 dataset ( n = 53). The median value of SLC38A5 expression is the cut-off for high and low expression. Results from three independent experiments are summarized in a histogram format. * P < 0.05, ** P < 0.01, *** P < 0.001

Journal: Journal of Translational Medicine

Article Title: SLC38A5 suppresses ferroptosis through glutamine-mediated activation of the PI3K/AKT/mTOR signaling in osteosarcoma

doi: 10.1186/s12967-024-05803-6

Figure Lengend Snippet: SLC38A5 is up-regulated in osteosarcoma and associated with a poor prognosis. ( A ) The expression patterns of SLC38A5 across various tumors in the TCGA dataset based on the TIMER database. ( B ) The relative mRNA level of SLC38A5 in tumor ( n = 12) and adjacent normal tissues ( n = 12) based on clinical samples. ( C ) The protein level of SLC38A5 was assessed in osteosarcoma tissues and adjacent normal counterparts using western blot. ( D ) The quantitative analysis of the western blot result. ( E-F ) The protein level of SLC38A5 in human osteoblastic cell (hFOB1.19) and osteosarcoma cell lines (HOS, Saos-2, MG63, U2OS, 143B). ( G ) The mRNA level of SLC38A5 in different cell lines. (H-I) Kaplan–Meier survival analysis of SLC38A5 in osteosarcoma based on the TARGET database ( n = 86) and GSE21257 dataset ( n = 53). The median value of SLC38A5 expression is the cut-off for high and low expression. Results from three independent experiments are summarized in a histogram format. * P < 0.05, ** P < 0.01, *** P < 0.001

Article Snippet: The human osteosarcoma cell lines HOS, Saos-2 and MG63 were purchased from Wuhan Servicebio Technology Co., Ltd.

Techniques: Expressing, Western Blot